The Clinical Trials Directive, which came into force in May 2004 in order to create a harmonised framework for clinical drug research across Europe, is still hampering such research, according to new findings presented at the European Cancer Conference.
A new and extraordinary $22 million gift to the University of Michigan Health System is making possible a new and extraordinary institute — one with a mission of supporting fundamental research to advance the understanding of the causes, treatment and prevention of a broad range of human diseases.
An international gathering of breast cancer survivors at a Sunshine Coast dragon boat regatta will allow researchers to conduct the world’s first study into the link between air travel and a swollen arm condition suffered by many breast cancer survivors.
A major international study led by University of Adelaide researchers has confirmed the benefits for premature babies of giving their pregnant mothers repeat doses of corticosteroids.
UT Southwestern Medical Center will receive $34 million from the National Institutes of Health to lead a wide-ranging collaborative initiative aimed at speeding the transfer of laboratory discoveries to new therapies that improve human health.
GenVec, Inc. (Nasdaq: GNVC) announced that it has entered into a collaborative research and development agreement (CRADA) with the U.S. Military Malaria Vaccine Program at the Walter Reed Army Institute of Research (WRAIR) and the Naval Medical Research Center (NMRC) for the development and pre-clinical testing of a malaria vaccine candidate against Plasmodium vivax (P. vivax).
The National Institutes of Health has awarded $22.5 million to a team of scientists centered at the Semel Institute for Neuroscience and Human Behavior at UCLA to fund the Consortium for Neuropsychiatric Phenomics (CNP), an interdisciplinary, campuswide effort to understand the biology underlying a variety of mental disorders.
In work that could lead to safe and effective techniques for gene therapy, MIT researchers have found a way to fine-tune the ability of biodegradable polymers to deliver genes.
More than 10 million people in the United State have cancer, and more than half of them are women. For those who could still give birth, cancer treatments might signal the end of their fertility.
Mayo Clinic has been a national leader in medical imaging research for decades. Now its expert research team has a new state-of-the-art home. On Sept. 10, 2007, leaders from Mayo Clinic, the Opus Group and the National Institutes of Health (NIH) will join in the dedication of the Opus Building, which houses the Mayo Clinic Imaging Research Center.